3:39
Helping Patients Understand MS Biomarkers and Take Control of Their Care – Dr. Ahmed Abdelhak
MD Newsline
1:53
What Clinicians Should Know About Interpreting MS Biomarkers – Dr. Ahmed Abdelhak
1:37
Using Biomarker Trajectories to Predict MS Progression and Treatment Response – Dr. Ahmed Abdelhak
1:59
Gene Editing and Multiple Sclerosis: How Close Are We Really? – Dr. Ahmed Abdelhak
1:23
The Overlooked Cells That Could Transform MS Treatment – Dr. Ahmed Abdelhak
1:38
Combining Fluid, Imaging, and Genetic Data to Advance MS Progression Monitoring – Dr. Ahmed Abdelhak
1:50
How Age, Sex, and BMI Affect Biomarker Interpretation in MS – Dr. Ahmed Abdelhak
Cross Specialty Collaboration in Multiple Sclerosis Research – Dr. Ahmed Abdelhak
1:05
Can Kappa Free Light Chains Replace CSF Oligoclonal Bands in MS Diagnosis – Dr. Ahmed Abdelhak
1:10
Multinational Study Reveals How GFAP and NFL Predict MS Progression – Dr. Ahmed Abdelhak
1:31
The Predictive Power of GFAP and NFL in Monitoring MS Progression – Dr Ahmed Abdelhak
1:33
The Relationship Between GFAP Concentrations and MS Lesion Activity – Dr. Ahmed Abdelhak
2:45
What GFAP and CHIT1 Reveal About How Multiple Sclerosis Progresses – Dr. Ahmed Abdelhak
1:41
New Insights Into Fluid Biomarkers and MS Progression Tracking – Dr. Ahmed Abdelhak
27:12
The Future of Multiple Sclerosis Research: Gene Editing, Biomarkers & AI – Dr. Ahmed Abdelhak
